POPULARITY
Categories
54 episodes with FACS
25 episodes with FACS
36 episodes with FACS
48 episodes with FACS
118 episodes with FACS
36 episodes with FACS
32 episodes with FACS
34 episodes with FACS
32 episodes with FACS
22 episodes with FACS
18 episodes with FACS
22 episodes with FACS
28 episodes with FACS
28 episodes with FACS
19 episodes with FACS
18 episodes with FACS
33 episodes with FACS
20 episodes with FACS
12 episodes with FACS
18 episodes with FACS
11 episodes with FACS
16 episodes with FACS
29 episodes with FACS
16 episodes with FACS
20 episodes with FACS
11 episodes with FACS
18 episodes with FACS
10 episodes with FACS
8 episodes with FACS
11 episodes with FACS
10 episodes with FACS
9 episodes with FACS
11 episodes with FACS
9 episodes with FACS
16 episodes with FACS
8 episodes with FACS
9 episodes with FACS
16 episodes with FACS
141 episodes with FACS
22 episodes with FACS
7 episodes with FACS
6 episodes with FACS
15 episodes with FACS
6 episodes with FACS
5 episodes with FACS
7 episodes with FACS
3 episodes with FACS
6 episodes with FACS
6 episodes with FACS
7 episodes with FACS
7 episodes with FACS
6 episodes with FACS
6 episodes with FACS
7 episodes with FACS
Every spring for over 50 years, the Trauma, Critical Care, and Acute Care Surgery conference, best known simply as the MATTOX conference, is held in Las Vegas (https://www.trauma-criticalcare.com/). The conference is unique in that it is entirely focused on practice-changing clinical education. It's a damn good time too! A favorite feature is the annual debates. Today, we are featuring a showdown between Drs. Bryan A. Cotton, MD, MPH and Marty A. Schreiber, MD, FACS, FCCM, FCRST (Hon), COL, MC, USAR as they debate REBOA as a Life-Saving Intervention in Hemorrhagic Shock. You can listen on the podcast or watch the debate with accompanying slides on our website or app. Let's get ready to RUMMMBLLLEEEE! TRAUMA SURGERY VIDEO ATLAS: https://behindtheknife.org/premium/trauma-surgery-video-atlasPreparing for the deadliest injuries is challenging, and currently available resources are limited. That is why we created the Behind the Knife Trauma Surgery Video Atlas. Be ready for the most complex injuries, like penetrating trauma to the neck, audible bleeding from the IVC, and pelvic hemorrhage, with 24 scenarios. Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more. If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium: https://behindtheknife.org/premiumOral Board Review: https://behindtheknife.org/oral-boardOral Board Simulator: https://behindtheknife.org/oral-board/simulatorGeneral Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US
In today's episode, we spoke with Neil D. Gross, MD, FACS. Dr Gross is the medical director of Perioperative Surgical Services, section chief of Oropharynx Cancer, Surgery, and professor of head and neck surgery at The University of Texas MD Anderson Cancer Center in Houston. In our exclusive interview, Dr Gross discussed the key biological and clinical distinctions between cutaneous squamous cell carcinoma (CSCC) and basal cell carcinoma (BCC), noting that although BCC is more indolent and less responsive to systemic therapies, including immunotherapy, CSCC carries a meaningful risk of nodal and distant metastases and has demonstrated robust responses to anti–PD-1 therapy, with approximately half of patients achieving a significant response.He emphasized the importance of early multidisciplinary evaluation, with resectability serving as a critical first branch point in treatment planning. For patients with unresectable or metastatic CSCC, anti–PD-1 therapy is now the established standard of care. For borderline resectable patients, such as those at risk for significant functional loss from surgery, upfront systemic therapy offers the potential to preserve function and achieve cure. For resectable, high-risk patients, Gross highlighted the role of adjuvant cemiplimab-rwlc (Libtayo) following surgery and radiation, based on data from the phase 3 C-POST trial (NCT03969004).The discussion also addressed toxicity considerations in elderly and immunocompromised patients, populations Gross described as particularly high risk and underserved. He noted that although anti–PD-1 therapies are generally well tolerated, serious toxicities remain possible, underscoring the importance of careful patient monitoring in both adjuvant and investigational neoadjuvant settings.Finally, Gross highlighted the actively accruing phase 3 NRG-HN014 trial (NCT06568172), a National Cancer Institute–sponsored cooperative group study open across the United States, Canada, and Australia, which is evaluating a neoadjuvant approach vs upfront surgery in patients with advanced resectable CSCC. He also noted that more mature data from C-POST, as well as long-term phase 2 neoadjuvant findings, are anticipated later this year. [CS1]https://faculty.mdanderson.org/profiles/neil_gross.html
Every spring for over 50 years, the Trauma, Critical Care, and Acute Care Surgery conference, best known simply as the MATTOX conference, is held in Las Vegas (https://www.trauma-criticalcare.com/). The conference is unique in that it is entirely focused on practice-changing clinical education. It's a damn good time too! A favorite feature is the annual debates. Today, we are featuring a showdown between Drs. Carlos V.R. Brown, MD, FACS and Katie W. Russell, MD as they debate WHETHER OR NOT PEDIATRIC PANCREATIC INJURIES CAN BE MANAGED NON-OPERATIVELY. You can listen on the podcast or watch the debate with accompanying slides on our website or app. Let's get ready to RUMMMBLLLEEEE! TRAUMA SURGERY VIDEO ATLAS: https://behindtheknife.org/premium/trauma-surgery-video-atlasPreparing for the deadliest injuries is challenging, and currently available resources are limited. That is why we created the Behind the Knife Trauma Surgery Video Atlas. Be ready for the most complex injuries, like penetrating trauma to the neck, audible bleeding from the IVC, and pelvic hemorrhage, with 24 scenarios. Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more. If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium: https://behindtheknife.org/premiumOral Board Review: https://behindtheknife.org/oral-boardOral Board Simulator: https://behindtheknife.org/oral-board/simulatorGeneral Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US
Download Chapter 1 of Breast Implants, Explant Surgery, and Breast Implant Illness — FREE → https://robert-whitfield-md-pllc.myklpages.com/l/ScrLbh In this episode, board-certified plastic surgeon Dr. Robert Whitfield joins the show to walk through his path from oncologic microsurgical reconstruction to a practice focused on implant removal (explant) surgery and holistic surgical recovery. Dr. Whitfield discusses his team's published research analyzing capsule tissue from hundreds of patients using PCR testing, and what that data shows about bacterial contamination rates compared to smaller prior studies. He explains how genetic variation in detox pathways — including methylation and glucuronidation — may influence how patients respond to surgical devices, and how his team uses this information as part of pre-surgical planning.
In this episode, Alex sits down with Sheila Barbarino, MD, FAAO, FAACS, FACS to talk about the fast-moving world of aesthetic medicine and what's coming next. They discuss how international travel and research are helping shape new treatment options, from emerging fillers to the next generation of neurotoxins. The conversation dives into practical medical-legal safety advice, including how small daily habits can protect both patients and practices. Finally, the episode highlights the expanding leadership of women in medical aesthetics and why that shift matters for the industry's future. 00:30 Aesthetics as a global industry 01:34 The intersection of medical safety and legal safety 05:06 How FDA regulation can create an innovation gap 16:45 Innovative new treatments and techniques for holistic treatment 23:15 The leadership role of women in aesthetics
In this episode, Morgan P. Lorio, MD, FACS, joins the podcast to discuss redefining spine care through more personalized and evidence-based treatment approaches. He explores why treatment plans can fail, shares insights from his work on transitional reliability, and explains the importance of establishing clear rules of engagement to improve communication, decision-making, and patient outcomes.
In this episode, Morgan P. Lorio, MD, FACS, joins the podcast to discuss redefining spine care through more personalized and evidence-based treatment approaches. He explores why treatment plans can fail, shares insights from his work on transitional reliability, and explains the importance of establishing clear rules of engagement to improve communication, decision-making, and patient outcomes.
In this episode, Morgan P. Lorio, MD, FACS, joins the podcast to discuss redefining spine care through more personalized and evidence-based treatment approaches. He explores why treatment plans can fail, shares insights from his work on transitional reliability, and explains the importance of establishing clear rules of engagement to improve communication, decision-making, and patient outcomes.
If you've been quietly wondering whether low testosterone is the reason you've stopped wanting to touch your wife — or stopped wanting to at all — this episode is for you. You'll walk away understanding why a hormone fix alone almost never brings back the connection you've lost, and what actually has to happen first. If you're not sure where to start, take the free "Why Is My Desire Low?" quiz at mylibidodoc.com/libido-quiz — it maps both the physical and emotional roots, and it's completely free.
Download Chapter 1 of Breast Implants, Explant Surgery, and Breast Implant Illness — FREE → https://robert-whitfield-md-pllc.myklpages.com/l/ScrLbh——————————————————————————Episode 175 Dr. Robert Whitfield sits down with Dr. Kim to unpack one of the most overlooked drivers of chronic illness — mold toxicity and its impact on the cell membrane, mitochondria, and lymphatic system. Dr. Kim shares his own health crisis (a heart attack at age 33 caused by undiagnosed Bartonella and mold toxin exposure) and explains how mycotoxins like aflatoxin, ochratoxin, and gliotoxin damage cell membranes, disrupt bile flow, fuel biofilm formation, and contribute to neuroinflammation, mast cell activation, and parasitic susceptibility. The conversation dives deep into the science of cell danger response, phospholipid membrane repair, drainage pathway support, and why aggressive detox protocols can backfire without proper preparation. Dr. Whitfield connects these findings to his clinical work with breast implant illness patients, including PCR testing data showing biofilm formation on breast implants and its relationship to environmental toxin exposure. Topics covered include: How mold toxicity can mimic cardiac symptoms and trigger misdiagnosis The role of phospholipids, SPM-based fish oil, and essential fatty acids in repairing damaged cell membranes Why biofilms form and how they protect bacteria, mold, and heavy metals from the immune system The gut-liver-bile connection and enterohepatic recirculation of mycotoxins Nervous system regulation, mast cell activation, and why "safety" must come before aggressive detox Practical guidance on binders, glutathione precautions, sleep hygiene, and pre-surgical detox protocols—————————————————————————— Ready to take the next step?Book a Discovery Call → https://discovery.drrobertwhitfield.com (https://discovery.drrobertwhitfield.com/)Learn about the SHARP Method (Strategic Holistic Accelerated Recovery Program) → https://www.drrobertwhitfield.com/sharpJoin Dr. Rob's Circle (private community, 390+ members) → https://drrobscircle.com (https://drrobscircle.com/)——————————————————————————Dr. Robert Whitfield, MD, FACS is a board-certified plastic surgeon in Austin, Texas, specializing in breast implant illness (BII), explant surgery, and holistic surgical recovery. He has performed 2,000+ explant procedures and patients travel from 40+ states and 15 countries to work with him.#BreastImplantIllness #Explant #SHARPMethod #ChronicInflammation #BreastImplantRemovalPinned Comment Grab Chapter 1 of my book completely free — it covers what breast implant illness actually is, the 3 steps I use with every patient, and a real patient story. No fluff.→ https://robert-whitfield-md-pllc.myklpages.com/l/ScrLbhComment SHARP below if you want more on surgical recovery.
Download Chapter 1 of Breast Implants, Explant Surgery, and Breast Implant Illness — FREE → https://robert-whitfield-md-pllc.myklpages.com/l/ScrLbh——————————————————————————Episode 174 What does recovery from implant removal actually look like — week by week, month by month, for a full year? In this episode, Dr. Robert Whitfield sits down with Violet, a nurse practitioner who joined his Austin practice after years working in facial plastics in New York City — and who ultimately became a patient herself. —————————————————————————— Ready to take the next step?Book a Discovery Call → https://discovery.drrobertwhitfield.com (https://discovery.drrobertwhitfield.com/)Learn about the SHARP Method (Strategic Holistic Accelerated Recovery Program) → https://www.drrobertwhitfield.com/sharpJoin Dr. Rob's Circle (private community, 390+ members) → https://drrobscircle.com (https://drrobscircle.com/)——————————————————————————Dr. Robert Whitfield, MD, FACS is a board-certified plastic surgeon in Austin, Texas, specializing in breast implant illness (BII), explant surgery, and holistic surgical recovery. He has performed 2,000+ explant procedures and patients travel from 40+ states and 15 countries to work with him.#BreastImplantIllness #Explant #SHARPMethod #ChronicInflammation #BreastImplantRemovalPinned Comment Grab Chapter 1 of my book completely free — it covers what breast implant illness actually is, the 3 steps I use with every patient, and a real patient story. No fluff.→ https://robert-whitfield-md-pllc.myklpages.com/l/ScrLbhComment SHARP below if you want more on surgical recovery.
In this episode, Thomas K Varghese, Jr, MD, FACS, is joined by Serena Lofftus, MD, and James Wu, MD, FACS, from UCLA. They discuss Drs Lofftus and Wu's recent article, “Patient-Based Decision Making for Opioid Prescriptions After Ambulatory Breast Operation: A Randomized Clinical Trial,” which evaluated whether incorporating patient choice into postoperative prescribing decisions could reduce opioid prescribing and consumption after ambulatory breast operation without negatively affecting pain control or quality of life. Disclosure Information: Drs Varghese, Lofftus, and Wu have no relevant financial conflicts of interest to disclose. To earn 0.25 AMA PRA Category 1 Credits™ for this episode of the JACS Operative Word Podcast, click here to register for the course and complete the evaluation. Listeners can earn CME credit for this podcast for up to 2 years after the original air date. Lofftus, Serena Y MD1,4; Graham, Danielle S MD, PhD1,4; Le, Julie MD, FACS1,2; Zhu, Catherine Y MD1,3; Kaufman, Noy MD4,5; Huy, Tess C MD1,4; Kusske, Amy M MD, FACS1,4; Teshome, Mediget MD, FACS1,4; Baker, Jennifer L MD, FACS1,4; Wu, James X MD, FACS4,6. Patient-Based Decision Making for Opioid Prescriptions After Ambulatory Breast Operation: A Randomized Clinical Trial. Journal of the American College of Surgeons ():10.1097/XCS.0000000000001974, April 13, 2026. | DOI: 10.1097/XCS.0000000000001974 Learn more about the Journal of the American College of Surgeons, a monthly peer-reviewed journal publishing original contributions on all aspects of surgery, including scientific articles, collective reviews, experimental investigations, and more. #JACSOperativeWord
Capitulo 257 de Negocios de Otro Planeta conversando con Alexis Brantes, CEO dee AyL Business School, Head of Consumer Neuroscience Insights de UserEmotion, sobre neurociencias, Pikachu y Pokemon, las emociones, las microexpresiones faciales, el sistema FACS y el Facial Coding. Si quieres conectar con Alexis su Linkedin es https://www.linkedin.com/in/abrantesr/ y si quieres conocer mas de UserEmotion https://useremotion.com/es/ Si quieres conocer los libros de Alexis estos son https://www.amazon.com.mx/stores/Alexis-Brantes/author/B08MY968YP?ref=dbs_a_mng_rwt_scns_share&isDramIntegrated=true&shoppingPortalEnabled=true Si te gusto el podcast suscríbete, estaré haciendo mas como estos, dale me gusta y compártelo para que otros lo puedan disfrutar.
In oncology, performance is not just about getting patients in the door. It is about getting them to the right specialist, at the right time, with less friction across every handoff. This episode features a presentation from the ROI-Centered Care Summit, a half-day virtual summit produced by Bright Spots Ventures in partnership with TytoCare and the American Telemedicine Association (ATA). In this episode, Yarrow McConnell, MD, FACS, Chief Medical Officer at MultiCare Cancer Institute, shares how MultiCare redesigned oncology pathways to improve access, strengthen coordination, and deliver measurable ROI. You'll hear how MultiCare is: Using AI chart scrubbing to identify cancer diagnoses and concerning imaging findings earlier Deploying nurse navigators to accelerate intake and reduce barriers to care Building APP-staffed workup clinics to move patients more quickly from referral to consult Creating disease teams to improve handoffs and reduce siloed care Standardizing scheduling and authorization workflows, with virtual options built in Improving staging and comorbidity documentation to better reflect complexity and reimbursement Key topics include referral lag, nurse navigation, specialty coordination, scheduling friction, and the connection between operational redesign and financial performance. MultiCare reported a 9% year-over-year increase in operating margin, an increase in likelihood to recommend from 97.86 to 98.41, and a 17% year-over-year increase in teamwork scores. If you are a health system leader, oncology executive, specialty operations leader, or care transformation leader working to improve specialty access and reduce friction across the patient journey, this episode offers a practical look at what it takes to build specialty pathways that perform. Link to Dr. Yarrow McConnel's Presentation: https://www.brightspotsinhealthcare.com/wp-content/uploads/2026/06/ROI-navigation-AIintake-McConnell-2026.pdf Bio: Yarrow McConnell, MD, MSc, FACS, FSSO, is a board-certified surgical oncologist, specializing in the treatment of breast cancer and benign breast disorders. Her expertise includes lumpectomy, mastectomy, sentinel node biopsy, and axillary dissection. She is also highly skilled in oncoplastic techniques to restore breast contour and symmetry following cancer surgery. For patients pursuing reconstruction, Dr. McConnell performs skin and nipple sparing mastectomies in close collaboration with plastic surgeons to provide both immediate and delayed reconstruction options. She also offers flat aesthetic closure for those who choose not to undergo reconstruction. In complex cases involving inflammatory, recurrent, or locally advanced breast cancer, she is experienced in performing modified radical and radical mastectomies. In addition to cancer care, Dr. McConnell treats a variety of benign breast conditions through both in-office and surgical procedures, including cyst aspiration, duct excision, abscess drainage, and steroid injections. She also provides comprehensive breast cancer risk assessments and guidance on genetic testing, enhanced screening, and prevention strategies. Dr. McConnell leads the Breast Program at MultiCare Cancer Institute, overseeing the coordination and advancement of breast care services across the system. Outside of work, Dr. McConnell enjoys gardening, baking, woodworking, and knitting. She can often be found hiking with her husband and dogs or spending time with family and friends. Thank You to Our Episode Partner, TytoCare. TytoCare enables health systems and plans to deliver high-quality remote exams anytime, anywhere. Their FDA-cleared devices and AI-powered diagnostic platform support virtual specialty care, school-based programs, and home health models, reducing unnecessary ED visits and improving patient experience. To learn more, visit tytocare.com. Schedule a Meeting with a Senior Leader at TytoCare: To explore how TytoCare can help your organization expand virtual specialty access and improve care coordination, reach out to jtenzer@brightspotsventures.com to schedule a meeting. About Bright Spots Ventures: Bright Spots Ventures exists to help healthcare organizations accelerate the adoption of what's actually working. Healthcare does not suffer from a lack of innovation. It suffers from slow adoption, fragmented learning, and limited trust between stakeholders. For example, one health plan or provider may solve a major operational or clinical challenge while others spend the next 5–10 years rediscovering the same answer. We close that gap by creating trusted environments where health plans, providers, and innovators can share practical strategies, operational lessons, and scalable models that drive measurable improvement. Through the Bright Spots in Healthcare podcast, leadership councils, executive roundtables, curated events, and strategic advisory work, we help organizations build credibility, strengthen strategic relationships, and accelerate the spread of proven ideas across healthcare.
CommonSpirit Health hosted a Grand Rounds session discussing the treatment of menopausal symptoms in women with cancer. The discussion included strategies on optimizing quality of life with oncologic safety. Speaker:Marina Frimer, MD, FACOG, FACS, Associate Chief, Research and Academic Development, Central Region; Director, Clinical Cancer Research, Northwell Health Cancer Institute at Rego Park; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Long Island Jewish Medical Center; Associate Professor, Donald and Barbara Zucker School of Medicine at Hofstra/NorthwellPanelist:Claire Hoppenot, MD, Assistant Professor, Gynecologic Oncology, Dan L. Duncan Comprehensive Cancer Center, Baylor College of MedicineModerator: Amy Brockmeyer, MD, Section Head of Gynecologic Oncology, Department of Surgery, Virginia Mason Franciscan Health
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/WXE865. CME/AAPA/IPCE credit will be available until June 16, 2027.Maximizing NMIBC Outcomes: Personalized, Risk-Adapted Approaches With Intravesical Therapy and Collaborative Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Ferring Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/WXE865. CME/AAPA/IPCE credit will be available until June 16, 2027.Maximizing NMIBC Outcomes: Personalized, Risk-Adapted Approaches With Intravesical Therapy and Collaborative Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Ferring Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/WXE865. CME/AAPA/IPCE credit will be available until June 16, 2027.Maximizing NMIBC Outcomes: Personalized, Risk-Adapted Approaches With Intravesical Therapy and Collaborative Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Ferring Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/WXE865. CME/AAPA/IPCE credit will be available until June 16, 2027.Maximizing NMIBC Outcomes: Personalized, Risk-Adapted Approaches With Intravesical Therapy and Collaborative Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Ferring Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/WXE865. CME/AAPA/IPCE credit will be available until June 16, 2027.Maximizing NMIBC Outcomes: Personalized, Risk-Adapted Approaches With Intravesical Therapy and Collaborative Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Ferring Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/WXE865. CME/AAPA/IPCE credit will be available until June 16, 2027.Maximizing NMIBC Outcomes: Personalized, Risk-Adapted Approaches With Intravesical Therapy and Collaborative Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Ferring Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.
In this episode, we sit down with Dr. Sharon Webb, founder and lead physician of Southern Regenerative and Neurological Wellness. Dr. Webb is a board-certified neurosurgeon with more than two decades of experience in neurological surgery, endovascular neurosurgery, and regenerative medicine. She earned her medical degree from the University of South Carolina School of Medicine and holds distinguished fellowships including FAANS, FACS, and FAHA.During our conversation, Dr. Webb shares her journey from treating complex brain and spine disorders in hospital systems to pioneering a more integrative approach that combines neurosurgery, regenerative medicine, and neurological wellness. We discuss brain health, recovery from neurological injuries, chronic pain, innovative regenerative therapies, and what the future of personalized medicine could look like for patients seeking better outcomes and improved quality of life.Whether you're interested in neuroscience, health optimization, regenerative medicine, or the latest approaches to neurological recovery, this episode offers valuable insights from one of the field's leading experts.Thank you so much for listening! If you would like to see more from Southern Regenerative & Neurological Wellness, you can find them here:Website: https://www.southernrnw.com/This episode is sponsored by Columbia Family Chiropractic: https://www.cfcforhealth.comhttps://www.instagram.com/columbiafamilychiropracticThis episode is sponsored by Gallup Design Build: https://www.gallupdesignbuild.comhttps://www.instagram.com/gallupdesignbuildIf you would like to follow us, we are on everything at Here For The Health Of It Podcast:https://www.instagram.com/columbiashottestpodcast/https://podcasters.spotify.com/pod/show/hereforthehealthofit
With a growing reliance on GLP-1 treatments for obesity, researchers at Vanderbilt University in Nashville, Tennessee, compared body composition changes between patients who used GLP-1s versus patients who underwent bariatric surgery for obesity treatment. In this episode, host Rick Greene, MD, FACS, talks with Jason M. Samuels, MD, FACS, one of the authors of Body Composition Changes After Bariatric Surgery or Treatment With GLP-1 Receptor Agonists about the findings, which showed that while both treatments reduced fat mass, surgery helped preserve fat-free mass such as muscle and organ tissues. Talk about the podcast on social media using the hashtag #SurgicalReadings
GLP-1 medications like Ozempic and Wegovy are changing bodies fast. But what happens to your skin, face and overall appearance after dramatic weight loss? In this episode, Lauren sits down with New York Plastic & Reconstructive Surgeon Dr. David Kashan to talk about the growing rise in “Ozempic face,” loose skin, body contouring, facelifts, skin removal surgery and the very real aesthetic side effects many people aren't talking about. Dr. Kashan, who trained at the renowned Cleveland Clinic, shares what he's seeing firsthand in his practice during the GLP-1 boom. Together, they discuss who is most affected by rapid weight loss, the most common procedures patients are requesting now, how long patients should stop GLP-1 medications before surgery, and whether non-surgical treatments can help improve skin laxity, facial volume loss and overall skin quality before considering surgery. If you're a woman in midlife navigating weight loss, aging, confidence, skin changes or considering GLP-1 medications yourself, this conversation is packed with honest insight, practical advice, and expert perspective you'll definitely want to hear. Show Notes David L. Kashan MD, FACS, Plastic & Reconstructive Surgery (516) 515-9267 Website: davidkashanmd.com Instagram: @davidkashanmd
Sustaining critical care delivery in today's healthcare environment requires more than resilience—it also calls for collective solutions to systemic challenges. In this episode of the Society of Critical Care Medicine (SCCM) Podcast, Past President Jose L. Pascual, MD, PhD, FRCS(C), FACS, FCCM, elaborates on the session presented during the 2026 Critical Care Congress, Critical Care Under Pressure: Sustaining the Workforce and Infrastructure Amid Rising Demands. Joined by host Marilyn Bulloch, PharmD, BCPS, FCCM, Dr. Pascual examines the complex forces reshaping critical care, from shrinking ICU capacity and hospital closures to persistent workforce shortages and shifting training pipelines. He highlights concerning trends such as reduced entry into certain critical care pathways, particularly anesthesiology. At the same time, he points to encouraging growth in other pathways, with increasing participation from clinicians in emergency medicine, neurology, and surgery. The conversation underscores disparities in access to care, particularly for rural and community hospitals. Dr. Pascual explores the tension between the regionalization of specialized care and the need to maintain equitable access across health systems, emphasizing the importance of thoughtful resource distribution and collaboration across institutions. Beyond workforce numbers, the evolution of leadership in critical care is also impactful, including the migration of experienced clinicians into administrative roles and the potential need for cyclical leadership models that maintain clinical engagement. Meeting these challenges requires innovation and cooperation. Dr. Pascual highlights advancements in education, particularly the expansion of simulation-based training, as critical tools for maintaining competency and improving team performance. Resources referenced in this episode: 2026 Congress Digital
George O. Waring IV, MD, FACS, speaks with Dagny C. Zhu, MD, about refractive lens exchange and her same-day bilateral refractive lens exchange workflow in an office-based surgery setting. Dr. Zhu discusses how refractive lens exchange fits into her cash-pay refractive practice, how her team screens and evaluates candidates, and the steps involved when patients proceed from consultation to surgery on the same day. She also shares her approach to diagnostic testing, patient counseling, premium IOL selection, oral sedation, femtosecond laser sequencing, refractive accuracy, and IOL calculations in eyes with a history of corneal refractive surgery.
In this episode, Lillian Erdahl, MD, FACS, is joined by Pringl Miller, MD, FACS, from Physican Just Equity, and Christine Heisler, MD, FACS, from the Mayo Clinic Health System. They discuss Drs Miller and Heisler's recent article, “Whether and How Surgeons Took Action Against Workplace Microaggression: Survey of American College of Surgeons Members,” in which the authors found that the most frequent perpetrator roles were surgeon colleagues and supervisors. A total of 57.4% of surgeons took action, with informal reporting to a colleague and/or directly confronting the perpetrator being most common actions taken. Surgeons who took action were less likely to choose a career in surgery again. Disclosure Information: Drs Erdahl, Miller, and Heisler have nothing to disclose. To earn 0.25 AMA PRA Category 1 Credits™ for this episode of the JACS Operative Word Podcast, click here to register for the course and complete the evaluation. Listeners can earn CME credit for this podcast for up to 2 years after the original air date. Heisler, Christine A MD, MS, FACS; Godecker, Amy L PhD, MS; Verran, Deborah MbChB, MHSM; Sinha, Michael S MD, JD, MPH; Byam, Jerome MD; Miller, Pringl MD, FACS. Whether and How Surgeons Took Action Against Workplace Microaggression: Survey of the American College of Surgeons Members. Journal of the American College of Surgeons 242(2):p 390-400, February 2026. | DOI: 10.1097/XCS.0000000000001648 Related work: Primary Study: Heisler CA, Godecker AL, Verran D, Sinha MS, Byam J, Miller P. Workplace microaggressions: results of a survey of the American College of Surgeons members. Am J Obstet Gynecol. 2024 Aug;231(2):265.e1-265.e8. Secondary Study: Heisler CA, Godecker AL, Verran D, Sinha MS, Byam J, Miller P. Impact of Workplace Microaggressions on Surgeon Career Status and Trajectory: A Cross-Sectional Survey Study. Accepted to the Annals of Surgery Open on April 30, 2026. The secondary study was also presented at ACS Clinical Congress 2024: Heisler CA, Godecker A, Verran D, Sinha MS, Byam J, Miller P. Workplace Microaggressions and the Impact on a Surgeon's Career Trajectory: Results of a Survey of the American College of Surgeons Members. J Am Coll Surg. October 2024;239(5):S138-139. Learn more about the Journal of the American College of Surgeons, a monthly peer-reviewed journal publishing original contributions on all aspects of surgery, including scientific articles, collective reviews, experimental investigations, and more. #JACSOperativeWord
Event ObjectivesImplement at least one subtractive change in their practices.Understand the scope of healthcare delivery's environmental impact.Perform procedures with less materials waste and use.Claim CME Credit Here!
Please visit answersincme.com/860/101385133-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Peter A. Fasching, MD; Michael Gnant, MD, FACS; and Cristina Saura Manich, MD, PhD. In this activity, experts in breast cancer discuss new evidence in neoadjuvant and adjuvant care of early disease. Upon completion of this activity, participants should be better able to: Describe multidisciplinary viewpoints on the role that HER2-directed ADCs may play in the (neo)adjuvant setting for HER2-positive early-stage breast cancer; Evaluate evidence for the (neo)adjuvant use of HER2-directed ADCs in the multidisciplinary management of HER2-positive early-stage breast cancer; and Formulate evidence-based multidisciplinary strategies to optimally incorporate (neo)adjuvant HER2-directed ADCs into the treatment paradigm for HER2-positive early-stage breast cancer.
In this episode, Stephen B. Williams, MD, MBA, MS, FACS, FACHE, Associate Chief Medical Officer, UTMB Clear Lake, Medical Director for High Value Care, UTMB Health System, Chief, Division of Urology, Professor (Tenured), Urology and Radiology, The Robert Earl Cone Professorship, Director of Urologic Oncology, The University of Texas Medical Branch,discusses physician leadership, operational transformation, and the growing impact of artificial intelligence in healthcare.
We're talking about Breast Implant Illness — BII. An estimated 400,000 women believe their implants are making them sick. Tens of thousands of adverse reports have been filed with the FDA. And with roughly 300,000 implant procedures performed every year in the US, this is a public health conversation we can no longer ignore. Women are reporting fatigue, brain fog, joint pain, hair loss, and autoimmune-like symptoms — often dismissed by doctors for years. The research is ongoing, but the FDA has added new warnings, and the conversation around patient safety and informed consent is finally gaining real traction Our guest, Sean Doherty, MD, FACS, is a board-certified plastic surgeon in Boston. Dr. Doherty is seeing an increasing number of patients seeking guidance on BII, including those considering implant removal or replacement. KEY TAKEAWAYS 1. How breast implant illness (BII) is defined, and what has contributed to the growing awareness around it in recent years The most common symptoms in patients who are concerned about BII When a patient is concerned about possible breast implant illness, what the evaluation process looks like—from the first conversation through deciding next steps The risk factors or patient profiles that may make someone more susceptible to complications or symptoms associated with breast implants For patients who believe they may be experiencing BII, the options that are available to them How the field of plastic surgery has evolved in recent years to better prioritize patient safety, informed consent, and long-term outcomes when it comes to breast implants Is there such a thing as a safer implant or one designed for autoimmune patients? è You can learn about his services at: https://www.seandohertymd.com/ è You can find the links in the show notes at https://ronandlisa.com/podcast/. è Be sure to leave a review or rating – five stars are always appreciated. And, if you're not already subscribed…consider this your whisper!
In this episode, R. Lawrence Moss, MD, FACS, FAAP, President and Chief Executive Officer, Nemours Children's Health, discusses why investing in childhood health can transform long-term outcomes for society, the role of healthcare systems in addressing social determinants of health, and Nemours Children's innovative work in kindergarten readiness and pediatric global budgeting.
In this episode live from Hawaiian Eye 2026, Cathleen McCabe, MD speaks with Marguerite McDonald, MD, FACS about her fascinating career that has spanned many decades. From shocking stories about ophthalmic research to being the first woman to pioneer a number of leadership roles in the field, Dr. McDonald shares her journey. We'd love to hear from you! Send your comments/questions to podcast@healio.com. Follow us on Twitter @Healio_OSN. Mend the Gap would also like to give you the chance to nominate yourself or a colleague for a travel grant! To enter, simply email us at podcast@healio.com! · Welcome to this episode 1:23 · Marguerite McDonald, MD, FACS 1:35 · Tell us about your career, how did you start? 4:30 · How did you become the first person in the world to perform corneal refractive surgery? 9:27 · Radial keratotomy and a lawsuit 16:07 · Refractive surgery research 20:10 · Facing criticism 29:13 · Any motivating words for our audience? 35:12 · Thank you! 37:34 Cathleen McCabe, MD, is chief medical officer of Eye Health America and medical director of The Eye Associates in Sarasota, Florida. Marguerite McDonald, MD, FACS, is a clinical professor of ophthalmology at NYU Langone Health and in private practice with OCLI in Long Island, NY.
In this episode, R. Lawrence Moss, MD, FACS, FAAP, President and Chief Executive Officer, Nemours Children's Health, discusses why investing in childhood health can transform long-term outcomes for society, the role of healthcare systems in addressing social determinants of health, and Nemours Children's innovative work in kindergarten readiness and pediatric global budgeting.
In this episode of The House of Surgery, Drs. Katrin Arnolds and Ana Pena discuss the realities of operating while pregnant. Drawing from their own experiences as surgeons and mothers, they share practical tips for staying safe and comfortable in the OR, managing prenatal appointments, navigating workplace expectations, and reducing exposure to radiation, anesthesia gases, surgical smoke, chemotherapy agents, and other potential hazards. This conversation offers valuable insight for pregnant surgeons, trainees, and anyone working alongside pregnant members of the surgical team. Talk about the podcast on social media using the hashtag #HouseofSurgery Katrin Arnolds, MD, is a board-certified minimally invasive gynecologic surgeon at the Cleveland Clinic in Weston, Florida Ana Pena, MD, FACS, is a board-certified general surgeon at the Cleveland Clinic in Weston, Florida Copyright © 2026 by the American College of Surgeons (ACS). All rights reserved. The contents of this podcast may be cited in academic publications but otherwise may not be reproduced, disseminated, or transmitted in any form by any means without the express written permission of ACS. These materials may not be resold nor used to create revenue-generating content by any entity other than the ACS without the express written permission of the ACS. The contents of these materials are strictly prohibited from being uploaded, shared, or incorporated in any third-party applications, platforms, software, or websites without prior written authorization from the ACS. This restriction explicitly includes, but is not limited to, the integration of ACS content into tools leveraging artificial intelligence (AI), machine learning, large language models, or generative AI technologies and infrastructures.
You've watched him pull away and wondered if something is actually wrong with his body — and you were right to wonder. Dr. Arthur Burnett, Johns Hopkins urologist, breaks down exactly what testosterone does (and doesn't) do for men's drive, erections, and mood — and why a basic blood test isn't the whole picture. If your husband has quietly gone cold and neither of you knows why, take the free "Why Is My Drive Low?" quiz at mylibidodoc.com/libido-quiz — it takes three minutes and points you toward real answers.
What are the experts saying about thyroid cancer treatment in 2025? Maybe it's time to discuss deescalation of aggressive surgical care for lower risk thyroid cancers. We can accept that less surgery may be appropriate in select cases, including more thyroid lobectomies versus total thyroidectomies, consider less invasive approaches such as percutaneous ablation techniques, and utilize more observation with active surveillance. Early assessment of treatment may allow appropriate reduction in use of radioactive iodine ablation and more relaxed routine monitoring can reduce surveillance burden to patients and providers. Hosts: - Amanda Doubleday, DO, MBA, Assistant Professor, Waukesha Surgical Specialists, ProHealth Care. Affiliated with University of Wisconsin School of Medicine and Public Health, Department of Surgery. - Simon Holoubek, DO, MPH, Assistant Professor, University of Wisconsin School of Medicine and Public Health, Department of Surgery. - Alexander Chiu, MD, Assistant Professor, University of Wisconsin School of Medicine and Public Health, Department of Surgery. - Rebecca S Sippel, MD, FACS, Professor and Chair of Division of Endocrine Surgery, Vice Chair of Academic Affairs and Professional Development, University of Wisconsin School of Medicine and Public Health, Department of Surgery. Learning Objectives:- Risk stratification system now includes 4 categories: low, low-intermediate, high-intermediate, and high-TSH suppression targets are simplified: below the normal range if there is structural or biochemical disease and in the normal range if disease free. - Thyroid lobectomy is recommended for tumors < 2cm cT1N0 tumors and can be considered for tumors 2-4 cm. - Micro-Papillary Thyroid Carcinoma (
Catch up if you can!
In this episode of Eyeluminaries, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from Hawaiian Eye 2026 with guests Elizabeth Yeu, MD, and Allen C. Ho, MD. They discuss cataract and retina surgery, managing work-life balance and more. · Welcome to Eyeluminaries. 00:01 · Elizabeth Yeu, MD, 00:11 · How do you see Implantable Collamer Lens (ICL, STAAR Surgical) surgery expanding? 01:23 · How long have you been with Tarsus Pharmaceuticals? 05:00 · How do you have work-life balance? 08:21 · Allen C. Ho, MD 11:38 · What got you into retina? 12:55 · How has the evolution of retina surgery changed your practice? 14:55 · Tell us about your role at Eyecelerator. 17:00 · How do you manage your work-life balance? 18:39 · Thank you! 20:19 Elizabeth Yeu, MD, is an ophthalmologist and cornea and cataract surgeon. She is the chief medical officer of Tarsus Pharmaceuticals as well as past president of the American Society of Cataract and Refractive Surgery. Allen C. Ho, MD, is a retina surgeon at Wills Eye Hospital, past president of the Retina Society and Eyecelerator retina program chair. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John A. Hovanesian, MD, FACS @DrHovanesian on Instagram and X and John Hovanesian on LinkedIn.
How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences.In this episode, Dr Camidge sat down with Robert A Meguid, MD, MPH, FACS, a thoracic and cardiac surgeon, as well as a professor of cardiothoracic surgery, at the University of Colorado in Aurora.Drs Camidge and Meguid discussed Dr Meguid's journey into medicine, which was heavily influenced by his parents, both of whom were academic physicians. A first-generation American, Dr Meguid grew up watching his father operate and working in his father's research lab, experiences that ignited a lifelong interest in the scientific method and patient care. Dr Meguid pursued a combined 8-year medical program before matching into a residency in general surgery. During his residency, he spent 3 years in research, earning a master's degree in public health and shifting his focus toward surgical outcomes and risk analysis. After completing a cardiothoracic fellowship, he joined the University of Colorado, where he helped expand the thoracic surgery program and pioneered robotic-assisted techniques.A shift in Dr Meguid's perspective occurred when he suffered a life-threatening medical event during a family vacation in Australia. He contracted fulminant septic shock resulting from human metapneumovirus and group A strep, leading to respiratory and renal failure. After being intubated for several weeks and losing significant muscle mass, he was life-flighted back to his own ICU in Denver to begin recovery. This experience as a patient, during which he had to relearn how to stand and move, deepened his empathy and reinforced his commitment to patient-centered care.Currently, Dr Meguid is a leader in his field, focusing on thoracic oncology and complex chest wall reconstructions, such as that of the adult pectus excavatum. He remains dedicated to academic research on surgical risk assessment, ensuring that patients are empowered to make informed decisions about their care.
This mini-series on Behind the Knife delves into the technical aspects of the Operative Standards for Cancer Surgery, developed through the American College of Surgeons Cancer Research Program and Cancer Surgery Standards Program. This episode highlights sentinel lymph node biopsy for breast cancer.Hosts:- Lexy (Alexandra) Adams, MD, MPH (@lexyadams16) is a Surgical Oncology fellow at MD Anderson Cancer Center.- Lauren Postlewait, MD, FACS, is an Associate Professor of Surgery at Emory University School of Medicine and is the Medical Director of the Breast Center at Grady Memorial Hospital in Atlanta, GA.- Chantal Reyna, MD, FACS (@kprgrl3) is a Breast surgical oncologist at Loyola University Medical Center in Chicago, IL and serves as the oncology clinical lead for the breast service line.Guest:- Susan E. Pories, MD, FACS (@SusanPoriesMD) is a professor of surgery, vice chair for quality and safety, and director of the Rutger's Breast Center at the University hospital. Learning Objectives: - Understand the definition and identification of axillary sentinel lymph node. - Understand the technique for injecting tracer or dye to perform sentinel lymph node biopsy. - Understand the importance of preincision drainage evaluation and transcutaneous localization.- Understand techniques to minimize seroma formation.Links to Papers Referenced in this EpisodeOperative Standards for Cancer Surgery, Volume 1: Breast, Lung, Pancreas, Colonhttps://www.facs.org/quality-programs/cancer-programs/cancer-surgery-standards-program/operative-standards-for-cancer-surgery/purchase/Kindle edition:https://www.amazon.com/Operative-Standards-Cancer-Surgery-Section-ebook/dp/B07MWSNFSBSentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial Lancet Oncol. 2010 Oct;11(10):927-33.https://pubmed.ncbi.nlm.nih.gov/20863759/Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection J Clin Oncol. 2016 Apr 1;34(10):1072-8.https://pubmed.ncbi.nlm.nih.gov/26811528/The false-negative rate of sentinel node biopsy in patients with breast cancer: a meta-analysis World J Surg. 2012 Sep;36(9):2239-51. https://pubmed.ncbi.nlm.nih.gov/22569745/Effect of lymphoscintigraphy drainage patterns on sentinel lymph node biopsy in patients with breast cancer Am J Surg. 2005 Oct;190(4):557-62.https://pubmed.ncbi.nlm.nih.gov/16164919/Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial JAMA Oncol. 2023 Nov 1;9(11):1557-1564.https://pubmed.ncbi.nlm.nih.gov/37733364/Choosing Wisely GuidelinesSociety of Surgical Oncology. Released 2016 July 12; last updated 2020 November 13. Choosing Wisely: Five Things Physicians and Patients Should Question.https://surgonc.org/wp-content/uploads/2020/11/SSO-5things-List_2020-Updates-11-2020.pdfPlease visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more. If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium:General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewOral Board Simulator: https://app.behindtheknife.org/oral-board-simulatorTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PRZ865. CME/MOC/CC/AAPA/IPCE credit will be available until April 20, 2027.Blocking Type 2 Inflammation in CRSwNP With Targeted Biologic Therapy: Personalizing Care to Achieve Improved Patient Outcomes In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PRZ865. CME/MOC/CC/AAPA/IPCE credit will be available until April 20, 2027.Blocking Type 2 Inflammation in CRSwNP With Targeted Biologic Therapy: Personalizing Care to Achieve Improved Patient Outcomes In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.
In this episode, Thomas K Varghese, Jr, MD, FACS, is joined by Carrie Chan, MSN, MPH, from the University of California, San Francisco, and Karthik Balakrishnan, MD, FACS, from Stanford Medicine Children's Health. They discuss their recent article,“Development, Validation, and Comparison of Machine Learning Models for Predicting Pediatric Surgical Site Infections Using the NSQIP-P Database,” which represents the largest study to date on predicting pediatric surgical site infection. The authors developed machine-learning models and ultimately recommend a regularized logistic regression model for clinical integration, balancing performance and feasibility for implementation. Findings support using routine preoperative data for personalized infection prevention and preoperative planning. Disclosure Information: Ms Chan and Drs Varghese and Balakrishnan have nothing to disclose. To earn 0.25 AMA PRA Category 1 Credits™ for this episode of the JACS Operative Word Podcast, click here to register for the course and complete the evaluation. Listeners can earn CME credit for this podcast for up to 2 years after the original air date. Chan, Carrie T MSN, MPH; Pletcher, Mark J MD, MPH; Balakrishnan, Karthik MD, MPH, FACS; Hswen, Yulin ScD, MPH; Scheffler, Aaron PhD, MS. Development, Validation, and Comparison of Machine Learning Models for Predicting Pediatric Surgical Site Infections Using the NSQIP-P Database. Journal of the American College of Surgeons 242(3):p 712-722, March 2026. | DOI: 10.1097/XCS.0000000000001683 Learn more about the Journal of the American College of Surgeons, a monthly peer-reviewed journal publishing original contributions on all aspects of surgery, including scientific articles, collective reviews, experimental investigations, and more. #JACSOperativeWord
In this episode, Richard Evans, MD, FACS, of Westchester Medical Center Health Network's Western Region and Assistant Professor at New York Medical College, joins the podcast to discuss addressing workforce shortages through innovative education programs. He shares how hands-on training and expanding students' exposure to different career paths are helping build a stronger, more prepared healthcare workforce for the future.
In this episode, Dr. Paula Ferrada, MD, FACS, FCCM, MAMSE, Department of Surgery Chair, Inova Fairfax Hospital, shares how data, trust, and teamwork are transforming perioperative operations, improving access, and boosting efficiency while keeping patients at the center of care.This episode is sponsored by LeanTaaS.
In this segment of Cancer Registry World, Laurie Kirstein, MD, FACS, a breast surgical oncologist in the Division of Surgical Oncology at Memorial Sloan Kettering Cancer Center and current Chair of the American College of Surgeons Commission on Cancer (CoC), discusses her vision and priorities for the CoC. Drawing on the power of cancer registry data, she highlights the essential role Oncology Data Specialists play in advancing cancer care, quality measurement, and program improvement. Tune in to hear how data-driven insights are shaping the future of oncology.
In this episode, Jeffrey Cohen, MD, FACS, FASCRS, CPE, Executive Vice President and Chief Clinical Operating Officer at Hartford HealthCare, joins the podcast to discuss breakthroughs in outpatient care management and how data is improving safety and quality. He shares insights on HHC 2035 and the shift toward a more consumer-centric healthcare system, along with ways Hartford Healthcare is enhancing the overall patient experience.
In this episode, Neil Tanna, MD, MBA, FACS, Senior Vice President of System Perioperative Services & Strategy at Northwell Health, joins the podcast to discuss the growing potential of AI in surgical and perioperative care. He shares the importance of strong stakeholder engagement and how access to reliable, actionable data is critical to driving better decision-making and improving outcomes across the system.
In this episode, Morgan P. Lorio, MD, FACS, Past President, International Society for the Advancement of Spine Surgery (ISASS), discusses the growing role of AI in spine care and its impact on clinical decision-making, policy, and medical knowledge. He highlights the importance of physician-led governance to ensure technology enhances rather than erodes critical thinking and patient-centered care.
© 2020-2026 Ivy Podcast Discovery LLC
